2329 — Glory Health Industry Cashflow Statement
0.000.00%
- HK$160.00m
- HK$26.94bn
- CNY2.71bn
Annual cashflow statement for Glory Health Industry, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | — |
Source: | ARS | ARS | ARS | ARS | |
Standards: | IFRS | IFRS | IFRS | IFRS | — |
Status: | Final | Final | Final | Final | fx Preliminary |
Net Income/Starting Line | 517 | 877 | -1,090 | -679 | — |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | -134 | -32.3 | 1,025 | 237 | — |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 4,465 | 3,407 | 574 | 870 | — |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 4,938 | 4,345 | 606 | 513 | — |
Capital Expenditures | -273 | -280 | -193 | -60.8 | — |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -2,505 | 464 | -113 | 120 | — |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -2,778 | 184 | -305 | 59 | — |
Financing Cash Flow Items | 535 | -3,094 | -220 | -448 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,113 | -5,654 | -631 | -627 | — |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1,048 | -1,125 | -330 | -55.5 | — |